Five things for pharma marketers to know: Friday, January 20, 2017

Five things for pharma marketers to know: Friday, January 20, 2017

Pharma among top sponsors of Trump inauguration parties; AstraZeneca exec to replace GSK president of global pharmaceuticals; EpiPen rival to relaunch

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Wunderman Health taps former Merkle exec as SVP of strategy and analytics

Deborah Furey will lead the agency's pilot of a new personalized marketing offering.

MM&M opens nominations for Hall of Femme

MM&M opens nominations for Hall of Femme

MM&M last year named its inaugural class of 16 Femmes and 20 Women to Watch. Who should be considered for this year's list of breakthough women?

Women, Sometimes Too Risk-Averse, Should Instead Focus on Possibility

Women, Sometimes Too Risk-Averse, Should Instead Focus on Possibility

Think back on your career. Did you take the "riskier" assignments?

Industry hires and promotions: January 2017

Industry hires and promotions: January 2017

Endo hires new head of U.S. branded pharma, and three other people moves for you to know about.

If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold

If CSL Limited CEO Paul Perreault sneezes, Australia gets a cold

"In Australia, we are the healthcare industry," he says.

Tonic Life promotes Stephanie DeViteri to MD

Tonic Life promotes Stephanie DeViteri to MD

DeViteri started in the newly created role this month.

MMC's Diana Littman on waiting for a decision after a pitch

MMC's Diana Littman on waiting for a decision after a pitch

She says her experience in consumer brands helps her push healthcare clients to be more creative.

QuintilesIMS taps Staub as head of R&D solutions

QuintilesIMS taps Staub as head of R&D solutions

The merger of Quintiles and IMS Health closed in October.

Five things for pharma marketers to know: Wednesday, January 4, 2017

Five things for pharma marketers to know: Wednesday, January 4, 2017

Sanofi, Regeneron denied bid to overturn Amgen win in patent case; Abbott to close St. Jude deal; Gilead hires SVP of hematology and oncology

The next generation: Q&As with 3 agency staffers

The next generation: Q&As with 3 agency staffers

MM&M conducted Q&As with Stephanie Robinson, senior account manager, The Bloc; Jessica Hill, account supervisor, Ogilvy CommonHealth; and Austin Bald, account executive, TBWA\WorldHealth.

A look back: Q&As with Lester Barnett, C. Marshall Paul, and Steve Girgenti

A look back: Q&As with Lester Barnett, C. Marshall Paul, and Steve Girgenti

Read what they have to say about the defining moments and challenges in their careers.

Millennial staffers at agencies seek work-life balance and strong supervisors

Millennial staffers at agencies seek work-life balance and strong supervisors

Many young staffers agree one of the biggest challenges in their careers has been learning the delicate balance of when to speak up and when to listen.

Five things for pharma marketers to know: Tuesday, December 13, 2016

Five things for pharma marketers to know: Tuesday, December 13, 2016

Lilly to offer discounts for insulin products; Trump reportedly considering Scott Gottlieb to lead FDA; three execs depart Valeant

Five things for pharma marketers to know: Friday, December 9, 2016

Five things for pharma marketers to know: Friday, December 9, 2016

BMS to pay $19.5 million to settle marketing violations for Abilify; AstraZeneca to cut 700 U.S. jobs; Trump reportedly considering Jim O'Neill to lead FDA

Spectrum names Jonathan Wilson CEO

Spectrum names Jonathan Wilson CEO

Wilson will succeed founder and CEO John Seng.

Rock Health's Bill Evans on finding a career with meaning

Rock Health's Bill Evans on finding a career with meaning

The Roche veteran says that people who work in digital health need to touch others in a meaningful way.

Five things for pharma marketers to know: Monday, December 5, 2016

Five things for pharma marketers to know: Monday, December 5, 2016

The FDA approves new indication for Jardiance; Novartis' CAR-T therapy eliminates leukemia in 82% of patients in trial; doctors report risks associated with immunotherapy

Gilead's Meyers on making deals and finding unmet patient needs

Gilead's Meyers on making deals and finding unmet patient needs

The drugmaker's new EVP of worldwide commercial operations also talks about tackling medication access, product launches, and starting a commercial team from scratch.

Paying Lip Service to STEM Isn't Enough

Paying Lip Service to STEM Isn't Enough

I'm not suggesting that colleges become vocational schools. But don't you think they should also help young people prepare for the life they're going to be living?

OPINION

Email Newsletters